title: A newly detected mutation of the RET protooncogene in exon 8 as a cause of multiple endocrine neoplasia type 2A.
abstract: Multiple endocrine neoplasia type 2A (MEN2A) is a syndrome of familial neoplasias characterized by medullary thyroid carcinoma (MTC), pheochromocytoma and hyperplasia of the parathyroid glands. RET protooncogene mutations are responsible for MEN 2A. Mutations in exons 10 or 11 have been identified in more than 96% of patients with MEN 2A. We herein report for the first time a patient with MEN 2A harboring a mutation (Gly(533)Cys) in exon 8. A 66-year old male patient was referred to our department for bilateral adrenal nodules. The patient's family history was remarkable in that his mother had pheochromocytoma. Biochemical evaluation and findings of the magnetic resonance imaging of the adrenals were compatible with the diagnosis of bilateral pheochromocytomas. The patient underwent laparoscopic bilateral adrenalectomy and histological examination confirmed the preoperative diagnosis of pheochromocytoma. Absence of phenotypic characteristics of VHL or NF1 and elevated calcitonin levels both basal and post pentagastrin stimulation, raised the possibility of MEN 2A syndrome. Total thyroidectomy was performed and histological examination showed the presence of MTC. Direct sequencing of exon 8 from the patient's genomic DNA revealed the mutation c.1,597G-->T (Gly533Cys). Although this missense point mutation has been associated with familial MTC (FMTC), to the best of our knowledge mutations in exon 8 have not previously been identified in patients with MEN 2A. In conclusion, in patients with clinical suspicion of MEN 2A syndrome, analysis of RET exon 8 should be considered when the routine evaluation of MEN 2A-associated mutations is negative. Furthermore, patients with FMTC and exon 8 mutations should also be screened for pheochromocytoma.
authors: Department of Endocrinology, Athens Polyclinic, Athens, Greece.
authors: Sotirios
authors: S
authors: Bethanis
authors: George
authors: G
authors: Koutsodontis
authors: Theodosia
authors: T
authors: Palouka
authors: Christos
authors: C
authors: Avgoustis
authors: Drakoulis
authors: D
authors: Yannoukakos
authors: Thalia
authors: T
authors: Bei
authors: Savas
authors: S
authors: Papadopoulos
authors: Dimitrios
authors: D
authors: Linos
authors: Stylianos
authors: S
authors: Tsagarakis
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism; D000311:Adrenal Glands / Q000473:pathology; D000368:Aged; D001483:Base Sequence; D003545:Cysteine; D005091:Exons; D005998:Glycine; D006147:Guanine; D006801:Humans; D007150:Immunohistochemistry; D008279:Magnetic Resonance Imaging; D008297:Male; D008969:Molecular Sequence Data; D018813:Multiple Endocrine Neoplasia Type 2a / Q000175:diagnosis / Q000235:genetics*; D009154:Mutation; D010375:Pedigree; D010673:Pheochromocytoma / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism; D051096:Proto-Oncogene Proteins c-ret / Q000235:genetics*; D013941:Thymine
chemical_list: D006147:Guanine; D051096:Proto-Oncogene Proteins c-ret; D003545:Cysteine; D013941:Thymine; D005998:Glycine